- Bloomberg•54 minutes ago
Scott Bauer, senior market strategist at Trading Advantage, discusses the performance of U.S. stocks and his options play for Amgen. He speaks with Bloomberg's Julie Hyman on "Bloomberg Markets." ...
- Reuters•1 hour ago
Amgen Inc on Thursday reported higher-than-expected third-quarter profit on lower research and manufacturing costs and onetime payments, and the world's largest biotechnology company raised its full-year earnings forecast for the third successive quarter. Amgen slightly raised the low end of its revenue forecast and now expects $22.6 billion to $22.8 billion. Excluding items, Amgen posted adjusted earnings of $3.02 per share, topping analysts' average expectations by 23 cents, according to Thomson Reuters I/B/E/S.
- MarketWatch•2 hours ago
Shares of Amgen Inc. fell 1.3% in after-hours trade Thursday, after the biotechnology company beat third-quarter earnings expectations and raised its profit outlook, but kept its sales outlook virtually ...
Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||158.60 x 100|
|Ask||159.00 x 500|
|Day's Range||159.64 - 161.60|
|52wk Range||139.02 - 176.85|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||16.43|
|Avg Vol (3m)||2,798,181|
|Dividend & Yield||4.00 (2.53%)|